Home › Hypertrophic Cardiomyopathy › Massachusetts
Hypertrophic Cardiomyopathy clinical trials in Massachusetts
6 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Boston
- Imbria Investigational Site, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Boston Children's Hospital, Boston
RecruitingPhase 2
Ages 8 and older · Men · Updated May 4, 2026 · NCT06092034HCMR Re-Imaging Study
- Brigham & Women's Hospital, Boston
- Tufts Medical Center, Medford
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Mar 18, 2026 · NCT07054073Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
- Analysis Group Inc., Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 7, 2024 · NCT06551129From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.